Skip to main content
Cyril Barbezange on Muck Rack

Cyril Barbezange

As seen in: The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Cyril

Contact Cyril, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Persistence of IgG response to SARS-CoV-2

|
By European Programme, Cyril Barbezange, Els Duysburgh, Laure Mortgat
| The Lancet Verified
1 Gudbjartsson DF Norddahl GL Melsted P et al. Humoral immune response to SARS-CoV-2 in Iceland. N Engl J Med. 2020; 383: 1724-1734 and the USA, antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis. However, other studies have reported rapid waning of antibodies within 3–4 months. Little is known about the duration and protective capacity of the humoral immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Open in Who Shared Issue with article?

Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease

|
By Laurence Dedeken, Carole Nagant, Cyril Barbezange, Tatiana Besse-Hammer
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Carole Nagant , Cyril Barbezange, Laurence Dedeken, Tatiana Besse-Hammer, Isabelle Thomas, Bhavna Mahadeb, André Efira, Alice Ferster, Francis Corazza Carole Nagant, Cyril Barbezange, Laurence Dedeken, Tatiana Besse-Hammer, Isabelle Thomas, Bhavna Mahadeb, André Efira, Alice Ferster, Francis Corazza Published: October 10, 2019 https://doi.org/10.1371/journal.pone.0223991 Figures Abstract Introduction Patients suffering from Sickle...
Open in Who Shared Issue with article?
See all 2 articles